Gaviscon

Each 10ml of oral suspension contains 500 mg sodium alginate, 267 mg sodium bicarbonate and 160 mg calcium carbonate as the active ingredients. The product is sugar-free and colour-free. The patient can take this product if the patients is pregnant or breast feeding.
Excipients/Inactive Ingredients: 40mg methyl parahydroxybenzoate (E218), and 6mg propyl parahydroxybenzoate (E216) as preservative. It also contains carbomer, sodium saccharin, sodium hydroxide, natural mint flavour and purified water.

Gaviscon Liquid belongs to a group of medicines called "reflux suppressants", which form a protective layer on top of the stomach contents to prevent stomach add escaping from the stomach where it works into the food pipe where it hurts..
On ingestion, Gaviscon Liquid reacts with gastric acid precipitating alginic acid in the form of a viscous, frothy, colloidal gel of low specific gravity which floats on the gastric contents and physically suppresses reflux into the oesophagus. By physically preventing autodigestion, Gaviscon Liquid relieves pain and allows inflamed oesophageal tissue to recover. In severe cases, the gel itself may be refluxed into the oesophagus where it protects the inflamed mucosa thus allowing healing to take place and preventing further inflammation. Gaviscon Liquid is only active in stomach. On passing into the duodenum, the alginic acid gel is neutralised, giving a sodium alginate solution of low viscosity. There is no absorption from the alimentary tract and it is wholly excreted, so no systemic effects occur.

Gaviscon Liquid bring relief from the pain and discomfort of heartburn and acid indigestion which, for example, can occur after meals or during pregnancy.

For oral administration. Adults, including the elderly and children 12 years and over: One to two sachets, up to 4 times a day after meals and at bed time.
Adults and Children >12 years: 10-20 mL 4 times a day, after meals and before retiring.
Children <12 years: 5-10 mL after meals and before retiring.
Dosage may be repeated at other times if symptomatic relief is required.
Infants: Not recommended.

Allergy to any of the ingredients of Gaviscon Liquid as skin rashes and difficulty in breathing have been reported.

Before taking this product: Each sachet (10ml) of oral suspension contains 6.2 mmol of sodium and 1.6 mmol of calcium. If the patient have been advised a diet restricted in either of these, as is required in certain cases of hepatic, renal or cardiac failure, consult the doctor before taking this product. This product contains methyl (E218) and propyl (E216) parahydroxybenzoates which may cause allergic reactions (possibly delayed).
Do not take if the patient know he/she is allergic to any of the ingredients as skin rashes and difficulty in breathing have been reported.
Consult the doctor if the patient experience these or any other side effects.
After taking this product: If the patient forget a dose it is not necessary to double the dose next time, just carry on taking as before. If symptoms persist after seven days consult the doctor. If the patient take too much of the medicinal product the patient may feel bloated. It is unlikely to cause the patient any harm, but consult the doctor or pharmacist.
This treatment may be less effective if there is decreased amounts of gastric acid produced in the stomach.
If a dose is missed, it is not necessary to double the dose next time, continue medication as prescribed.
If symptoms persist after 7 days, consult the doctor.

Do not store above 30°C and store in the original package. Do not freeze.
Do not refrigerate the liquid and shake well before use.

Antacids, Antireflux Agents & Antiulcerants

A02A - ANTACIDS ; Used in the treatment of acid-related disorders.

NP